Health TrialsbyHealthPanel

Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM

Conditiondm
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorSherief Abd-Elsalam

About this trial

Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

NAFLD and type 2 DM

Disqualifiers

Viral hepatitis.

Child score more than 6.

renal impairment.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Vildagliptin

    Drug

    vildagliptin twice daily

  • vildagliptin\metformin

    Drug

    vildagliptin\\metformin twice daily

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: vildagliptinExperimental treatment 1 intervention
Group B: vildagliptin\metforminActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

number of patients with improved nafld and insulin resistance

number of patients showing improved nafld and insulin resistance

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov
Apply now